• Q-VD-OPh: Potent Pan-Caspase Inhibitor for Apoptosis Researc

  2026-05-30

  Q-VD-OPh is a highly potent, irreversible pan-caspase inhibitor targeting caspase-1, -3, -8, and -9 at nanomolar concentrations. It blocks caspase-mediated apoptotic pathways in vitro and in vivo, supporting robust apoptosis research. The compound is cell- and brain-permeable and is supplied by APExBIO for academic and translational studies.

• Fluorouracil (Adrucil): Unraveling Mechanisms and Immune Imp

  2026-05-29

  Explore how Fluorouracil (Adrucil) targets DNA replication and modulates tumor immunity, yielding novel insights for solid tumor research. This article integrates molecular mechanisms with emerging findings on immune resistance, advancing beyond standard protocols.

• Distinct Effects of Physiological vs Pathological Amyloid-β

  2026-05-29

  This study pioneers the use of live adult human brain slice cultures to directly compare the synaptic consequences of physiological and pathological amyloid-β (Aβ) exposure. The findings reveal that both increases and decreases in physiological Aβ disrupt synapse integrity, but only pathological Aβ causes synaptotoxicity without engaging compensatory synaptic gene responses—offering new insights for Alzheimer’s research and translational disease modeling.

• SU 5402: Optimizing RTK Inhibition in Cancer Biology Workflo

  2026-05-28

  SU 5402 streamlines targeted inhibition of receptor tyrosine kinases across cancer and neuronal research. Its performance in cell cycle arrest and apoptosis assays—especially in multiple myeloma and iPSC-derived neuronal models—makes it an indispensable tool for translational investigators.

• TRPV1+ Nerve Stimulation Suppresses Systemic Inflammation

  2026-05-28

  Song et al. (2025) demonstrate that targeted stimulation of TRPV1+ peripheral somatosensory nerves at the nape initiates a somato-autonomic reflex, rapidly suppressing systemic inflammation via neuro-immune pathways. This work offers mechanistic insight into neural regulation of inflammation and informs translational strategies for neuro-immune modulation.

• A23187, Free Acid: Calcium Ionophore Workflows & Troubleshoo

  2026-05-27

  A23187, free acid is the gold-standard calcium ionophore for precise modulation of intracellular Ca2+ flux, enabling robust apoptosis, phosphoinositide signaling, and contractility workflows. This guide translates recent advances and troubleshooting strategies into actionable protocols for high-impact in vitro research.

• EdU Imaging Kits (Cy5): Accelerating Vascular Remodeling Res

  2026-05-27

  Explore how EdU Imaging Kits (Cy5) empower translational researchers to dissect cell proliferation in complex vascular remodeling, with mechanistic insight into PAH and strategic, evidence-driven guidance for S-phase analysis, genotoxicity assessment, and beyond.

• Bafilomycin A1: Mechanistic Leverage for Translational Cell

  2026-05-26

  Translational researchers face mounting pressure to bridge fundamental cellular mechanisms with clinical potential, especially in fields such as cancer research and lysosomal dysfunction. This article explores how Bafilomycin A1, a gold-standard V-ATPase inhibitor, enables targeted manipulation of intracellular pH and organellar function, with actionable guidance on protocol optimization and strategic study design. Drawing on recent advances in centriolar satellite biology and integrating cross-domain insights, we outline a roadmap for leveraging Bafilomycin A1 in high-impact translational workflows.

• Propranolol: Mechanistic Leverage for Translational Discover

  2026-05-26

  This thought-leadership article unpacks the mechanistic depth and translational potential of Propranolol, a non-selective β-adrenergic receptor blocker, in modern biomedical research. By integrating new metabolomic evidence with practical workflow guidance and comparative insights, it positions APExBIO’s Propranolol (SKU: BA1217) as a strategic lever for researchers seeking to bridge foundational biology and therapeutic innovation. The article advances beyond conventional summaries, offering actionable perspectives for those targeting cardiovascular, neurobehavioral, and metabolic axes in both preclinical and clinical models.

• HPF: Selective Probe for Highly Reactive Oxygen Species Dete

  2026-05-25

  HPF (hydroxyphenyl fluorescein) enables precise, cell-permeable detection of highly reactive oxygen species (hROS) such as hydroxyl radicals and peroxynitrite. Its fluorescence is specifically activated by hROS, making it a benchmark tool for intracellular oxidative stress visualization. APExBIO’s HPF (C3384) is validated for high specificity and minimal background in research applications.

• EZ Cap Cy5 Firefly Luciferase mRNA: Dual-Mode Delivery Insig

  2026-05-25

  EZ Cap Cy5 Firefly Luciferase mRNA (5-moUTP) enables direct, real-time tracking of mRNA uptake and expression, transforming transfection optimization and dual-modality imaging. Its advanced chemical modifications provide robust translation and immune evasion, setting new benchmarks for gene delivery studies.

• Modeling HSV-1 Latency in Human iPSC-Derived Sensory Neurons

  2026-05-24

  This study establishes a scalable protocol for differentiating human-inducible pluripotent stem cells into sensory neurons capable of supporting latent HSV-1 infection and reactivation. The model enables detailed analysis of latency mechanisms in a human neuronal context, addressing a longstanding gap in neurovirology research.

• Targeted Doxycycline Nanoparticles for Abdominal Aortic Aneu

  2026-05-23

  This study introduces a precision nanomedicine system that delivers doxycycline directly to abdominal aortic aneurysm (AAA) lesions using bioactive tea polyphenol nanoparticles. The approach achieves targeted matrix metalloproteinase inhibition and multi-modal disease modulation, offering a potential pharmaceutical alternative to current surgical AAA management.

• TAK1-Mediated YAP Stabilization Drives Gastric Cancer Stemne

  2026-05-22

  This study uncovers how TGFβ-activated kinase 1 (TAK1) stabilizes yes-associated protein (YAP) to promote self-renewal and oncogenesis in gastric cancer stem cells (GCSCs). The mechanistic findings highlight TAK1 as a key regulator of tumorigenic properties and suggest new avenues for targeting stemness and chemoresistance in gastric cancer.

• Human iPSC Sensory Neuron Model for HSV-1 Latency and Reacti

  2026-05-22

  This study establishes a scalable protocol to differentiate human inducible pluripotent stem cells into sensory neurons, providing a robust in vitro model for herpes simplex virus 1 (HSV-1) latency and reactivation. The model offers new opportunities to dissect neuron-intrinsic mechanisms of HSV-1 persistence and supports therapeutic research beyond animal systems.

15575 records 1/1039 page Next 12345 下5页 Last page